Publications

Found 1 results
Filters: Author is E. Bibordi  [Clear All Filters]
2011
H. Teimori, Akbari, M. T., Hamid, M., Forouzandeh, M., and Bibordi, E., Analysis of CD38 and ZAP70 mRNA expression among cytogenetic subgroups of Iranian chronic-lymphocytic-leukemia patients, vol. 10, pp. 2415-2423, 2011.
Aerts JL, Gonzales MI and Topalian SL (2004). Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques 36: 84-97. PMid:14740490 Binet JL, Auquier A, Dighiero G, Chastang C, et al. (1981). A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206. http://dx.doi.org/10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V Catherwood MA, Matthews C, Niblock R, Dobbin E, et al. (2006). ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur. J. Haematol. 76: 294-298. http://dx.doi.org/10.1111/j.1600-0609.2005.00619.x PMid:16519700 Chen L, Zhang Y, Zheng W, Wu Y, et al. (2008). Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk. Res. 32: 1491-1498. http://dx.doi.org/10.1016/j.leukres.2008.02.005 PMid:18359082 Cheson BD, Bennett JM, Rai KR, Grever MR, et al. (1988). Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am. J. Hematol. 29: 152-163. http://dx.doi.org/10.1002/ajh.2830290307 PMid:3189311 Crespo M, Bosch F, Villamor N, Bellosillo B, et al. (2003). ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 348: 1764-1775. http://dx.doi.org/10.1056/NEJMoa023143 PMid:12724482 Damle RN, Wasil T, Fais F, Ghiotto F, et al. (1999). Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840-1847. PMid:10477712 Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, et al. (2006). Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108: 853-861. http://dx.doi.org/10.1182/blood-2005-12-4986 PMid:16601244 Ferrer A, Ollila J, Tobin G, Nagy B, et al. (2004). Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet. Cytogenet. 153: 69-72. http://dx.doi.org/10.1016/j.cancergencyto.2003.12.016 PMid:15325098 Hamblin TJ, Davis Z, Gardiner A, Oscier DG, et al. (1999). Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94: 1848-1854. PMid:10477713 Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, et al. (2002). CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99: 1023-1029. http://dx.doi.org/10.1182/blood.V99.3.1023 PMid:11807008 Ibrahim S, Keating M, Do KA, O’Brien S, et al. (2001). CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98: 181-186. http://dx.doi.org/10.1182/blood.V98.1.181 PMid:11418478 Kienle DL, Korz C, Hosch B, Benner A, et al. (2005). Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J. Clin. Oncol. 23: 3780-3792. http://dx.doi.org/10.1200/JCO.2005.02.568 PMid:15867199 Kim SZ, Chow KU, Kukoc-Zivojnov N, Boehrer S, et al. (2004). Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status. Leuk. Lymphoma 45: 2037-2045. http://dx.doi.org/10.1080/10428190410001714016 Krober A, Seiler T, Benner A, Bullinger L, et al. (2002). V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100: 1410-1416. PMid:12149225 Krober A, Bloehdorn J, Hafner S, Buhler A, et al. (2006). Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J. Clin. Oncol. 24: 969-975. http://dx.doi.org/10.1200/JCO.2005.03.7184 PMid:16418492 Moreno C and Montserrat E (2008). New prognostic markers in chronic lymphocytic leukemia. Blood Rev. 22: 211-219. http://dx.doi.org/10.1016/j.blre.2008.03.003 PMid:18448218 Orchard JA, Ibbotson RE, Davis Z, Wiestner A, et al. (2004). ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363: 105-111. http://dx.doi.org/10.1016/S0140-6736(03)15260-9 Rai KR, Sawitsky A, Cronkite EP, Chanana AD, et al. (1975). Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-234. PMid:1139039 Rassenti LZ, Huynh L, Toy TL, Chen L, et al. (2004). ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl. J. Med. 351: 893-901. http://dx.doi.org/10.1056/NEJMoa040857 PMid:15329427 Schroers R, Griesinger F, Trumper L, Haase D, et al. (2005). Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 19: 750-758. http://dx.doi.org/10.1038/sj.leu.2403707 PMid:15759031 Stamatopoulos B, Meuleman N, Haibe-Kains B, Duvillier H, et al. (2007). Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin. Chem. 53: 1757-1766. http://dx.doi.org/10.1373/clinchem.2007.089326 PMid:17702857 van’t Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, et al. (2006). The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91: 56-63. PMid:16434371 Wiestner A, Rosenwald A, Barry TS, Wright G, et al. (2003). ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101: 4944-4951. http://dx.doi.org/10.1182/blood-2002-10-3306 PMid:12595313